← Open Payments lookup

MUHAMMAD SHABBIR: Open Payments

NPI 1285879338 · MERCED, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$499 in 23 payments from 12 companies in 2025. Trend: 2023 $364 · 2024 $602 · 2025 $499

Food & beverage: $499
CompanyPaymentsAmount
GlaxoSmithKline, LLC.5$90
Novo Nordisk Inc3$83
AstraZeneca Pharmaceuticals LP3$54
Exact Sciences Corporation2$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$47
Lilly USA, LLC2$40
ABIOMED1$26
Abbott Laboratories1$24
Bayer Healthcare Pharmaceuticals Inc.1$23
Corcept Therapeutics1$23

Products named: SHINGRIX, Cologuard Collection Kit, CAPLYTA, MOUNJARO, BREZTRI, Rybelsus, TRELEGY ELLIPTA, Ozempic.

Industry payments across CA — which companies pay providers there.